IL15 and neoplasm: NKTR-255, a recombinant human IL-15 (rhIL-15) receptor agonist, can activate the IL-15 pathway and promote the proliferation of memory CD8+ T cells and Tscm subsets in tumor-specific T-cell colonies (101, 102).